In 2012, Fang et al. showed that, in animal models, mirtazapine inhibits tumour growth through immune system activation, testified by higher serum levels of IL-12, CD4+ and CD8+ and lower tumoural concentrations of TNF-α and IFN-γ [68]. The gene discussed is CD4; the disease is neoplasm.